• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Chronic Pancreatitis Pain - Pipeline Review, H2 2012 Product Image

Chronic Pancreatitis Pain - Pipeline Review, H2 2012

  • Published: July 2012
  • 30 pages
  • Global Markets Direct

Chronic Pancreatitis Pain – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'Chronic Pancreatitis Pain - Pipeline Review, H2 2012', provides an overview of the Chronic Pancreatitis Pain therapeutic pipeline. This report provides information on the therapeutic development for Chronic Pancreatitis Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Pancreatitis Pain. 'Chronic Pancreatitis Pain - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Chronic Pancreatitis Pain.
- A review of the Chronic Pancreatitis Pain products READ MORE >

2
List of Tables 3
List of Figures 4
Introduction 5
REPORT COVERAGE 5
Chronic Pancreatitis Pain Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Chronic Pancreatitis Pain 7
Chronic Pancreatitis Pain Therapeutics under Development by Companies 9
Chronic Pancreatitis Pain Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Chronic Pancreatitis Pain Therapeutics – Products under Development by Companies 14
Chronic Pancreatitis Pain Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Chronic Pancreatitis Pain Therapeutics Development 16
Axcan Pharma Inc. 16
Chronic Pancreatitis Pain – Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
Lyrica - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Pioglitazone - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
EUR-1066 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Namisol - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Chronic Pancreatitis Pain Therapeutics – Drug Profile Updates 26
Chronic Pancreatitis Pain Therapeutics – Discontinued Products 27
Chronic Pancreatitis Pain Therapeutics - Dormant Products 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30

List of Tables
Number of Products Under Development for Chronic Pancreatitis Pain, H2 2012 7
Products under Development for Chronic Pancreatitis Pain – Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Comparative Analysis by Early Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
Axcan Pharma Inc., H2 2012 16
Assessment by Monotherapy Products, H2 2012 17
Assessment by Stage and Route of Administration, H2 2012 19
Assessment by Stage and Molecule Type, H2 2012 21
Chronic Pancreatitis Pain Therapeutics – Drug Profile Updates 26
Chronic Pancreatitis Pain Therapeutics – Discontinued Products 27
Chronic Pancreatitis Pain Therapeutics – Dormant Products 28

List of Figures
Number of Products under Development for Chronic Pancreatitis Pain, H2 2012 7
Products under Development for Chronic Pancreatitis Pain – Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Early Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 17
Assessment by Route of Administration, H2 2012 18
Assessment by Stage and Route of Administration, H2 2012 19
Assessment by Molecule Type, H2 2012 20
Assessment by Stage and Molecule Type, H2 2012 21

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos